HALO logo
halo search icon
Tyra Bioscience, Inc
Tyra Bioscience, Inc
TYRA · NAS

Tyra Bioscience, Inc

US$33.02

Price Arrow-0.38 (-1.138%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Price MomentumHammer Bearish (Realtime)Recent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Tyra Bioscience, Inc Overview

TYRA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TYRA

icon

Website

Tyra Bioscience, Inc

icon

Telephone

1.619.728.4760

icon

Address

2656 State Street, Carlsbad, CA 92008

Description

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

TYRA Price Chart

Key Stats

Market Cap

US$1.99B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 8.75 - 40.65

Trade Value (12mth)

US$3,911,972.00

1 week

-9.83%

1 month

-10.58%

YTD

24.67%

1 year

248.28%

All time high

40.65

Key Fundamentals

EPS 3 yr Growth

52.40%

EBITDA Margin

0.00%

Operating Cashflow

-$95m

Free Cash Flow Return

-31.00%

ROIC

-39.10%

Interest Coverage

0.00

Quick Ratio

14.70

Other Data

Shares Outstanding (Fully Diluted)

62m

HALO Sector

Healthcare

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TYRA Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
17 April 26

TYRA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.62-1.51-2.01locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.62-1.51-2.01locklocklock
Growth
%locklocklocklock-22.66.6-33.1locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Tyra Bioscience, Inc (TYRA:NAS)?
Halo FAQ
The current share price of Tyra Bioscience, Inc (TYRA:NAS) is USD$33.02.
What is the 52-week high share price for Tyra Bioscience, Inc (TYRA:NAS)?
Halo FAQ
The 52-week high share price for Tyra Bioscience, Inc (TYRA:NAS) is USD$40.65.
What is the 52-week low share price for Tyra Bioscience, Inc (TYRA:NAS)?
Halo FAQ
The 52-week low share price for Tyra Bioscience, Inc (TYRA:NAS) is USD$8.75.
What is the dividend yield for Tyra Bioscience, Inc (TYRA:NAS)?
Halo FAQ
Tyra Bioscience, Inc (TYRA:NAS) does not pay a dividend.
What was Tyra Bioscience, Inc (TYRA:NAS) last dividend payment?
Halo FAQ
Tyra Bioscience, Inc (TYRA:NAS) does not pay a dividend.
What is the franking level for Tyra Bioscience, Inc (TYRA:NAS)?
Halo FAQ
Tyra Bioscience, Inc (TYRA:NAS) has a franking level of 0.00%.
In which sector is Tyra Bioscience, Inc (TYRA:NAS) classified?
Halo FAQ
Tyra Bioscience, Inc (TYRA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.